Abstract

Abstract Keloids are wounding‐induced fibroproliferative human tumor‐like skin scars of complex genetic makeup and poorly defined pathogenesis. To reveal dynamic epigenetic and transcriptome changes of keloid fibroblasts, we performed RNA ‐seq and ATAC ‐seq analysis on an early passage keloid fibroblast cell strain and its paired normal control fibroblasts. This keloid strain produced keloid‐like scars in a plasma clot‐based skin equivalent humanized keloid animal model. RNA ‐seq analysis reveals gene ontology terms including hepatic fibrosis, Wnt‐β‐catenin, TGF ‐β, regulation of epithelial‐mesenchymal transition ( EMT ), STAT 3 and adherens junction. ATAC ‐seq analysis suggests STAT 3 signalling is the most significantly enriched gene ontology term in keloid fibroblasts, followed by Wnt signalling (Wnt5) and regulation of the EMT pathway. Immunohistochemistry confirms that STAT 3 (Tyr705 phospho‐ STAT 3) is activated and β ‐ catenin is up‐regulated in the dermis of keloid clinical specimens and keloid skin equivalent implants from the humanized mouse model. A non‐linear dose‐response of cucurbitacin I, a selective JAK 2/ STAT 3 inhibitor, in collagen type I expression of keloid‐derived plasma clot‐based skin equivalents implicates a likely role of STAT 3 signalling in keloid pathogenesis. This work also demonstrates the utility of the recently established humanized keloid mouse model in exploring the mechanism of keloid formation.

Keywords

KeloidstatWnt signaling pathwayCancer researchBiologyWound healingMyofibroblastFibrosisMedicineCell biologyPathologySignal transductionImmunologySTAT3

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
article
Volume
28
Issue
4
Pages
480-484
Citations
46
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

46
OpenAlex

Cite This

Yun‐Shain Lee, Ya‐Chen Liang, Ping Wu et al. (2019). <scp>STAT</scp>3 signalling pathway is implicated in keloid pathogenesis by preliminary transcriptome and open chromatin analyses. Experimental Dermatology , 28 (4) , 480-484. https://doi.org/10.1111/exd.13923

Identifiers

DOI
10.1111/exd.13923